ABZORV Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for ABZORV with the United States Patent and Trademark Office. The USPTO has given the ABZORV trademark a serial number of 86451010. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 5, 2024. This trademark is owned by Glaxo Group Limited. The ABZORV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; Vaccines

General Information

Serial Number86451010
Word MarkABZORV
Filing DateTuesday, November 11, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 5, 2024
Registration Number5225672
Registration DateTuesday, June 20, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 15, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, January 5, 2024CANCELLED SEC. 8 (6-YR)
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 20, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 20, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, April 27, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, May 15, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 27, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, November 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2016SOU EXTENSION 2 GRANTED
Tuesday, October 18, 2016SOU EXTENSION 2 FILED
Tuesday, October 18, 2016SOU TEAS EXTENSION RECEIVED
Friday, May 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2016SOU EXTENSION 1 GRANTED
Thursday, April 14, 2016SOU EXTENSION 1 FILED
Tuesday, May 17, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 14, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, January 27, 2016PETITION TO DIRECTOR GRANTED
Tuesday, January 26, 2016ASSIGNED TO PETITION STAFF
Tuesday, January 5, 2016TEAS PETITION TO DIRECTOR RECEIVED
Friday, December 4, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 10, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 28, 2015APPLICANT SUPPLIED CHANGES/CORRECTIONS AFTER PUB APPROVAL NOT ENT
Tuesday, October 27, 2015ASSIGNED TO PETITION STAFF
Wednesday, October 14, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 2, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 2, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 25, 2015ASSIGNED TO LIE
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 18, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 11, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2015NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2015NON-FINAL ACTION WRITTEN
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 14, 2014NEW APPLICATION ENTERED

Related Keywords

abzorv disorders pharmaceutical treatment diseases preparations substances ophthalmic respiratory hepatological neurological